Bilateral Uterine Artery Ligation in Reducing Incidence of Postpartum Hemorrhage in Cesarean Section
Primary Purpose
Post Partum Hemorrhage
Status
Completed
Phase
Not Applicable
Locations
Egypt
Study Type
Interventional
Intervention
Oxytocin
bilateral uterine artery ligation
Sponsored by
About this trial
This is an interventional treatment trial for Post Partum Hemorrhage
Eligibility Criteria
Inclusion Criteria:
- Women with one or more of the following conditions undergoing cesarean section for obstetric indication were included:
- Maternal anemia (not less than 7 gm %).
- Macrosomic baby >4kgs.
- Twin pregnancy and high order pregnancy.
- Polyhydramnios.
- Grand multipara.
- Previous history of atonic postpartum hemorrhage.
- Prolonged vaginal delivery.
- Emergency cesarean.
- Chorioamnionitis.
Exclusion Criteria:
- - Placenta previa.
- Patients with bleeding tendency (congenital or acquired)
- Ante-partum hemorrhage.
- Patients with no risk for uterine atony.
Sites / Locations
- Ahmed Abbas
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
study group
control group
Arm Description
patients at risk of uterine atony undergoing cesarean section underwent bilateral uterine artery ligation and received oxytocin.
patients at risk of uterine atony undergoing cesarean section received oxytocin only.
Outcomes
Primary Outcome Measures
mean Blood loss after placental separation
by using weight of soaked towels (weight of soaked towel - weight of dry towel) and amount of blood in suction set
Secondary Outcome Measures
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT03591679
Brief Title
Bilateral Uterine Artery Ligation in Reducing Incidence of Postpartum Hemorrhage in Cesarean Section
Official Title
Role of Bilateral Uterine Artery Ligation in Reducing Incidence of Postpartum Hemorrhage in Cesarean Section in Patients At Risk of Uterine Atony A Randomized Controlled Trial
Study Type
Interventional
2. Study Status
Record Verification Date
March 2019
Overall Recruitment Status
Completed
Study Start Date
December 1, 2017 (Actual)
Primary Completion Date
November 30, 2018 (Actual)
Study Completion Date
January 1, 2019 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Assiut University
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
The patients were recruited from women attending labor ward to undergo cesarean section.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Post Partum Hemorrhage
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
1070 (Actual)
8. Arms, Groups, and Interventions
Arm Title
study group
Arm Type
Experimental
Arm Description
patients at risk of uterine atony undergoing cesarean section underwent bilateral uterine artery ligation and received oxytocin.
Arm Title
control group
Arm Type
Active Comparator
Arm Description
patients at risk of uterine atony undergoing cesarean section received oxytocin only.
Intervention Type
Drug
Intervention Name(s)
Oxytocin
Intervention Description
20 units by slow intravenous drip injection
Intervention Type
Procedure
Intervention Name(s)
bilateral uterine artery ligation
Intervention Description
• The peritoneum over the vesico-uterine pouch already being incised horizontally, the peritoneum over the uterine isthmus and cervix was dissected downwards, and this dissection was then extended laterally.
Primary Outcome Measure Information:
Title
mean Blood loss after placental separation
Description
by using weight of soaked towels (weight of soaked towel - weight of dry towel) and amount of blood in suction set
Time Frame
30 minutes
10. Eligibility
Sex
Female
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Women with one or more of the following conditions undergoing cesarean section for obstetric indication were included:
Maternal anemia (not less than 7 gm %).
Macrosomic baby >4kgs.
Twin pregnancy and high order pregnancy.
Polyhydramnios.
Grand multipara.
Previous history of atonic postpartum hemorrhage.
Prolonged vaginal delivery.
Emergency cesarean.
Chorioamnionitis.
Exclusion Criteria:
- Placenta previa.
Patients with bleeding tendency (congenital or acquired)
Ante-partum hemorrhage.
Patients with no risk for uterine atony.
Facility Information:
Facility Name
Ahmed Abbas
City
Assiut
State/Province
Cairo
ZIP/Postal Code
002
Country
Egypt
12. IPD Sharing Statement
Citations:
PubMed Identifier
31755559
Citation
Samy A, Ali MK, Abbas AM, Wahab HA, Wali AA, Hussien AH, Mostafa M, Taymour MA, Ogila AI, Ahmad Y, Essam A, Mahmoud M. Randomized controlled trial of the effect of bilateral uterine artery ligation during cesarean among women at risk of uterine atony. Int J Gynaecol Obstet. 2020 Feb;148(2):219-224. doi: 10.1002/ijgo.13064. Epub 2019 Dec 10.
Results Reference
derived
Learn more about this trial
Bilateral Uterine Artery Ligation in Reducing Incidence of Postpartum Hemorrhage in Cesarean Section
We'll reach out to this number within 24 hrs